Form 6-K NOVARTIS AG For: Oct 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall St set for lower open as oil prices jump, earnings in focus
- Brent hits five-month high as attacks on ships, Saudi sites fuel supply worries
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
- Cerebras Systems falls as TD Cowen cuts price target
- Nasdaq climbs as chip and AI-linked stocks bounce back
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
- 3M issues warrant to Amazon in $6B data center product deal
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
Novartis Q3 preview: BofA sees strong product momentum, potential EBIT Upgrade
October 27, 2025 4:00 PM EDTNovartis (NYSE: NVS) is set to report third-quarter results that Bank of America expects will be broadly in line with consensus, underpinned by strong prescription trends for key growth drivers.
According to BofA analyst Sachin Jain, the Neutral-rated drugmakers Q3 earnings per share are forecast at $2.30, up 12% year-on-year, on sales of about $14... More



